The scientist’s investigation covers issues in Breast cancer, Genome-wide association study, Single-nucleotide polymorphism, Genetics and Genetic predisposition. Research on Cancer and Internal medicine is a part of her Breast cancer study. Clare Turnbull interconnects Hazard ratio, Observational study, Public health and Emergency medicine in the investigation of issues within Cancer.
Clare Turnbull combines subjects such as Odds ratio, Estrogen receptor and Disease with her study of Genome-wide association study. Clare Turnbull has researched Single-nucleotide polymorphism in several fields, including Chromosome 12, Allele frequency and Testicular Germ Cell Tumor. The concepts of her Genetic predisposition study are interwoven with issues in Cancer research, Ovarian cancer and Bioinformatics.
Clare Turnbull spends much of her time researching Genetics, Cancer, Breast cancer, Genome-wide association study and Internal medicine. Her Cancer research includes themes of Observational study, Computational biology, Genetic testing and Emergency medicine. Her Breast cancer study incorporates themes from Colorectal cancer, PALB2, Family history and Hazard ratio.
Her Genome-wide association study study results in a more complete grasp of Single-nucleotide polymorphism. Her Single-nucleotide polymorphism study integrates concerns from other disciplines, such as Genotyping, Case-control study and Allele frequency. Her studies in Internal medicine integrate themes in fields like Germline mutation, Endocrinology and Oncology.
Her main research concerns Cancer, Breast cancer, Internal medicine, Emergency medicine and Oncology. Her Cancer research incorporates elements of Observational study, Gene, Medical genetics and Genetic testing. Her Medical genetics research incorporates themes from Genome-wide association study and Geneticist.
Her Genome-wide association study research includes elements of Estrogen receptor, Metastasis and Bioinformatics. The concepts of her Breast cancer study are interwoven with issues in Medical physics, Disease and Early detection. Her Oncology research incorporates elements of Polygenic risk score, Cancer susceptibility and Genetic association.
Clare Turnbull mainly investigates Cancer, Breast cancer, Emergency medicine, Pandemic and Public health. As part of the same scientific family, she usually focuses on Cancer, concentrating on Relative risk and intersecting with Cause of death, Survival rate, Genetic predisposition, Genome-wide association study and Heritability. Breast cancer is a subfield of Internal medicine that Clare Turnbull investigates.
Her Internal medicine study incorporates themes from Genetic association and Medical genetics. Her study looks at the relationship between Pandemic and topics such as Severe acute respiratory syndrome coronavirus 2, which overlap with Contact tracing. Her studies deal with areas such as Observational study and Hazard ratio as well as Public health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)
Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls
Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson.
Genome-wide association study identifies five new breast cancer susceptibility loci
Clare Turnbull;Shahana Ahmed;Jonathan Morrison;David Pernet.
Nature Genetics (2010)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius.
Nature Genetics (2015)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer.
Journal of the National Cancer Institute (2015)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday;Clare Turnbull;Emma Ramsay;Deborah Hughes.
Nature Genetics (2011)
Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Montserrat Garcia-Closas;Fergus J. Couch;Sara Lindstrom;Kyriaki Michailidou.
Nature Genetics (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: